china semaglutide Christian Schmollinger: China's first biosimilar Ozempic drug applies for approval, ETHealthworld China patent expiry and new

Saudi Pharmaceutical Journal : SPJ, 24(4), 413-428

[1] [2] It works by mimicking the action of naturally occurring GLP-1, a hormone that regulates blood glucose levels by stimulating insulin secretion, suppressing glucagon release, and slowing gastric emptying

Also, I want us to be thinking about our own biases more

Dizziness and low blood pressure symptoms can occur if you're taking certain diabetes medications simultaneously, making dose coordination with your healthcare provider essential during your first month

However, while Novo Nordisks stance against compounded medications may be framed as a measure to protect patient safety, theres also an undeniable commercial interest at play

These agonists aim to maximize metabolic benefits and minimize side effects